On May 11, 2020 Brazil’s ANVISA announces that the General Management of Drugs and Biological Products (GGMED) of Anvisa has a new flow for requesting and supplying copies of the registration process of drugs and active pharmaceutical ingredients (APIs).
Copy and paste this URL into your WordPress site to embed
